Fig. 3

Improvement in hypoglycemia (< 4 mmol/L) and hyperglycemia (> 20 mmol/L) in second comparison. Effect sizes with the 95% confidence interval (vertical line) on hypoglycemia (< 4 mmol/L) and hyperglycemia (> 20 mmol/L) where these outcomes within the first 3 months and subsequent 3 months of post-implementation at each of the 7 phases were compared with those from the 3 months period prior implementation